The North America Single-use Assemblies Market would witness market growth of 22.8% CAGR during the forecast period (2022-2028).
Industry associations and a few individual vendors have attempted to promote the general adoption of single-use standard designs. Changing verified manufacturing assemblies is a tough and resource-intensive endeavor, for starters, because it is too difficult and complex. Within firm networks, assembly design and procurement practices are inconsistent. End users typically advertise their own platforms rather than taking an industry-wide, holistic approach.
When standardization has been implemented, it has typically been the product of a site- and/or corporate-level push by the end user. The lack of standardization for single-use products has led to a proliferation of similar designs by numerous manufacturers. This has resulted in supply chain complexity, vast inventories, and a high number of stocks keeping units requiring substantial management resources.
Multiple vendors must produce fewer, high-quality standard SKUs for the single-use business. To enjoy the benefits of standardization, it is necessary to have a bold, long-term vision led by end-user companies. The development of a customized assembly for single usage begins with a specific design. This is a diagram of the assembly for the particular bioprocessing application. Using tubing or reinforced hose, closures, filters, fittings, sensors, bottles, and other components, every single-use assembly is custom-made.
There is a very wide prevalence of chronic diseases within North American countries. According to the New York Department of Health, six out of ten Americans have at least one chronic illness, such as heart disease, cancer, stroke, or diabetes. These and other chronic conditions are the main causes of death and disability in the United States, as well as a major factor in the expense of health care. Chronic diseases, such as cardiovascular disease, diabetes, cancer, stroke, and arthritis, are the main causes of mortality and disability in New York State and the United States as a whole.
The US market dominated the North America Single-use Assemblies Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $2,358.9 million by 2028. The Canada market is poised to grow at a CAGR of 25.6% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 24.5% during (2022 - 2028).
Based on Solution, the market is segmented into Standard Solutions and Customized Solutions. Based on Product, the market is segmented into Bag Assemblies, Filtration Assemblies, Bottle Assemblies, Mixing System Assemblies, and Others. Based on End User, the market is segmented into Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, and Academic & Research Institutes. Based on Application, the market is segmented into Filtration, Cell Culture & Mixing, Storage, Sampling, Fill-finish, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Single-use Assemblies Market is Estimated to reach $8.6 Billion by 2028, at a CAGR of 23.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Sartorius Stedim Biotech S.A. (Sartorius AG), Danaher Corporation, Merck Group, Avantor, Inc., Parker-Hannifin Corporation, Saint-Gobain Group (CertainTeed), Corning Incorporated, Repligen Corporation, and Entegris, Inc.
By Solution
By Product
By End User
By Application
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.